Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Revance Therapeutics (RVNC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2013	12-2012	12-2011	12-2006
Assets
Current Assets
Cash & Cash Equivalents	3,989	4,158	29,696	N/A
TOTAL	$4,814	$5,405	$30,119	$N/A

Non-Current Assets
PPE Net	14,315	6,980	8,439	N/A
Other Non-Current Assets	3,516	1,038	1,370	0
TOTAL	$17,831	$8,018	$9,809	$N/A

Total Assets	$22,645	$13,423	$39,928	$N/A

Liabilities
Current Liabilities
Short Term Debt	22,859	94,509	3,457	N/A
Accounts payable and accrued liabilities	5,526	1,805	777	0
Accrued Expenses	4,161	6,001	3,027	N/A
Other current liabilities	14,932	14,680	N/A	N/A
TOTAL	$47,561	$117,935	$8,855	$N/A

Non-Current Liabilities
Long Term Debt	2,632	10,995	18,430	N/A
Deferred Revenues	83	N/A	500	N/A
Other Non-Current Liabilities	2,843	2,739	58,943	0
TOTAL	$8,651	$16,782	$91,122	$N/A

Total Liabilities	$56,212	$134,717	$99,977	$N/A

Shareholders' Equity
Shares Outstanding, K	18,652	N/A	N/A	N/A
Retained earnings	-195,880	-218,326	-160,067	N/A
Other shareholders' equity	123,982	95,433	95,433	0
TOTAL	$-33,567	$-121,294	$-60,049	$N/A

Total Liabilities And Equity	$22,645	$13,423	$39,928	$0